IP Library Granted Patent US 7,378,405
Granted Patent B2
US 7,378,405 · App. 10/762,652 · Granted May 27, 2008

Stabilized steroid composition and method for its preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,378,405
App. No.
10/762,652
Granted
May 27, 2008
Kind
B2
Abstract

Stabilized 17-substituted hydrocortisone containing compositions and methods of manufacture. Isomerization of the hydrocortisone component of topical steroid compositions is markedly reduced by introducing an omega-6. acid in the form of linoleic acid into the skin preparation. Preferably, the linoleic acid is added as a component of refined safflower oil. The omega-6 acid has been found to be an effective way of preventing the isomerization of hydrocortisone 17-butyrate into the undesirable isomer HC21-B.

Claims (18)

1. A method for stabilizing a composition including hydrocortisone 17-butyrate therein, said method comprising the step of: adding an omega-6 acid to said composition.

2. The method of claim 1 , wherein said step of adding an omega-6 acid comprises adding linoleic acid to said composition.

3. The method of claim 1 , wherein said step of adding an omega-6 acid to said composition comprises adding safflower oil to said composition.

4. The method of claim 1 , wherein the step of adding an omega-6 acid further comprises adding said acid in an amount at least equimolar to a quantity of said hydrocortisone 17-butyrate.

5. The method of claim 4 , wherein said amount of acid is substantially greater than said quantity of hydrocortisone 17-butyrate.

6. A method for inhibiting the isomerization of hydrocortisone 17-butyrate to hydrocortisone 21-butyrate, said method comprising the step of: disposing said hydrocortisone 17-butyrate in a composition which includes an omega-6 acid therein.

7. The method of claim 6 , wherein the step of disposing said omega-6 acid comprises disposing linoleic acid.

8. The method of claim 6 , wherein the step of disposing said omega-3 acid comprises disposing omega-3 acid as a component of safflower oil.

9. The method of claim 6 , wherein the step of adding an omega-6 acid further comprises adding said acid in an amount at least equimolar to a quantity of said hydrocortisone 17-butyrate.

10. The method of claim 6 , wherein said amount of acid is substantially greater than said quantity of hydrocortisone 17-butyrate.

11. A method for stabilizing a hydrocortisone compound having an ester linkage at the 17 position, said method comprising the step of: disposing said hydrocortisone compound in a composition which includes an omega-6 acid therein.

12. The method of claim 11 , wherein the step of disposing said omega-6 acid comprises disposing linoleic acid.

13. The method of claim 11 , wherein the step of disposing said omega-6 acid comprises adding omega-6 acid as a component of safflower oil which is present in said composition.

14. The method of claim 13 , wherein the step of adding an omega-6 acid further comprises adding said acid in an amount at least equimolar to a quantity of said hydrocortisone 17-butyrate.

15. The method of claim 13 , wherein said amount of acid is substantially greater than said quantity of hydrocortisone 17-butyrate.

16. In a composition which includes hydrocortisone 17-butyrate therein, the improvement comprising in composition: said composition having an omega-6 acid therein in an amount sufficient to stabilize said hydrocortisone 17-butyrate.

17. A method for stabilizing a composition including a 17-substituted hydrocortisone, said method comprising the step of: adding an omega-6acid to said composition.

18. The method of claim 17 , wherein said 17-substituted hydrocortisone is a hydrocortisone ester.

Assignments (20)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY AGREEMENT Recorded Jul 6, 2015
From: ECR PHARMACEUTICALS CO., INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036091/0257 →
RELEASE OF SECURITY INTEREST Recorded Jul 7, 2014
From: GCI CAPITAL MARKETS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 033280/0556 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RELEASE OF SECURED PARTY PREVIOUSLY RECORDED ON REEL 013384 FRAME 0126. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTION OF DOC DATE FROM 4-25-2012 TO 9-9-2013. Recorded Oct 29, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031509/0788 →
RELEASE OF SECURITY INTEREST Recorded Sep 27, 2013
From: MIDCAP FUNDING III, LLC
To: PRECISION DERMATOLOGY COMPANY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN, LLC; PRECISION MD, LLC; TP CREAM SUB, LLC; TP LOTION SUB, LLC
Reel/Frame 031296/0492 →
SECURITY AGREEMENT Recorded Sep 20, 2013
From: PRECISION DERMATOLOGY, INC.
To: GCI CAPITAL MARKETS LLC
Reel/Frame 031249/0011 →
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031184/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2012
From: TRIAX PHARMACEUTICALS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 028828/0598 →
SECURITY AGREEMENT Recorded May 18, 2012
From: PRECISION DERMATOLOGY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN LLC; PRECISION MD LLC; TP CREAM SUB, LLC; TP LOTION SUB, LLC
To: MIDCAP FUNDING III, LLC
Reel/Frame 028234/0424 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2012
From: LAMINAR DIRECT CAPITAL, L.L.C. AS SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL, L.P.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028114/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2007
From: FERNDALE IP, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 020199/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2007
From: FERNDALE LABORATORIES, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 020240/0441 →
NOTICE OF GRANT OF SECURITY INTEREST Recorded Sep 25, 2007
From: TRIAX PHARMACEUTICALS, LLC
To: LAMINAR DIRECT CAPITAL L.P., AS COLLATERAL AGENT
Reel/Frame 019870/0970 →
REASSIGNMENT & RELEASE OF SECURITY INTEREST Recorded Sep 21, 2007
From: NATIONAL CITY BANK OF THE MIDWEST
To: FERNDALE IP, INC.
Reel/Frame 019881/0068 →
SECURITY AGREEMENT Recorded Sep 10, 2007
From: TRIAX PHARMACEUTICALS, LLC
To: FERNDALE LABORATORIES, INC.
Reel/Frame 019824/0647 →
SECURITY AGREEMENT Recorded Jul 26, 2006
From: FERNDALE IP, INC.
To: NATIONAL CITY BANK OF THE MIDWEST
Reel/Frame 017996/0505 →
RELEASE OF SECURITY INTEREST Recorded Jul 26, 2006
From: COMERICA BANK
To: FERNDALE IP, INC.
Reel/Frame 018006/0455 →
SECURITY AGREEMENT Recorded Apr 18, 2006
From: FERNDALE IP, INC.
To: COMERICA BANK
Reel/Frame 017480/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2005
From: FERNDALE LABORATORIES, INC.
To: FERNDALE, IP, INC.
Reel/Frame 016101/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2004
From: PATEL, PRAVIN M.
To: FERNDALE LABORATORIES, INC.
Reel/Frame 014924/0843 →